These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 23079745)

  • 1. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
    Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
    Li W; Sun Z; Chen C; Wang L; Geng Z; Tao J
    Biomed Pharmacother; 2018 Apr; 100():257-266. PubMed ID: 29438839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
    Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
    FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
    Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM
    Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
    Lin J; Huang S; Wu S; Ding J; Zhao Y; Liang L; Tian Q; Zha R; Zhan R; He X
    Carcinogenesis; 2011 Nov; 32(11):1641-7. PubMed ID: 21890460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
    J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.
    Liang L; Wong CM; Ying Q; Fan DN; Huang S; Ding J; Yao J; Yan M; Li J; Yao M; Ng IO; He X
    Hepatology; 2010 Nov; 52(5):1731-40. PubMed ID: 20827722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
    Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
    Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.
    Alpini G; Glaser SS; Zhang JP; Francis H; Han Y; Gong J; Stokes A; Francis T; Hughart N; Hubble L; Zhuang SM; Meng F
    J Hepatol; 2011 Dec; 55(6):1339-45. PubMed ID: 21703189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH; Shan H; Li D; Zhou B; Pang PF
    Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
    Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
    Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.